OLD Category: Oncology

MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer

• Weng Y.S. et. al.,

MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy

• Ogawa D et al.,

A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical Implications

• Gobin M. et. al.,

Expression of PD-1 by T Cells in Malignant Glioma Patients Reflects Exhaustion and Activation

• Davidson T.B. et al.,

Exome, transcriptome and miRNA analysis don’t reveal any molecular markers of TKI efficacy in primary CML patients

• Lavrov A.V. et. al.,

Expression of Cathepsins B, D, and G in WHO Grade I Meningioma

• Rahman R.M.A. et al.,

The emerging role of xanthine oxidase inhibition for suppression of breast cancer cell migration and metastasis associated with hypercholesterolemia

• Oh S.H. et. al.,

Endothelial miR-30c suppresses tumor growth via inhibition of TGF-β–induced Serpine1

• McCann J.V. et al.,

Identification of CD37, cystatin A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trial

• Dohm A, Su J, McTyre ER...Watabe K, Chan MD, Ruiz J

Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy

• Löck S et al.,

Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial

• Zelenetz A.D. et al.,

Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept study

• Cremolini C et. al.,